Genesia Ventures closes $113M Fund IV for seed-stage startups across Asia
What's the deal? Japan-based Genesia Ventures has completed the final close of its fourth fund at $113 million, targeting seed-stage startups across Japan, Southeast Asia, and India. The firm said it plans to be more selective this time, making fewer investments but deploying more capital into each portfolio company.
Fund IV is backed primarily by domestic and international institutional investors and financial institutions. Genesia operates from offices in Tokyo, Jakarta, Ho Chi Minh City, and Bengaluru.
Why now? The firm sees a convergence of forces — AI breakthroughs, energy transition, and Asia's economic rise — dissolving long-standing barriers to industrial progress. "I strongly believe this is an era in which startups have expanding opportunities to create major businesses and industries," said Takahiro Suzuki, head of overseas investments and general partner.
Genesia frames its thesis around what it calls an "Asia Origin" vision: the belief that globally significant companies will increasingly emerge from Asia's structural shifts rather than Western markets.
What could go wrong? Seed investing in emerging Asian markets carries well-known risks — thin exit markets, currency volatility, and regulatory unpredictability. A more concentrated portfolio strategy also raises the stakes on each individual bet. If a few key investments falter, the fund's returns could suffer disproportionately.
The signal: Genesia's approach reflects a broader trend among Asia-focused VCs: moving away from spray-and-pray seed strategies toward higher-conviction, deeper-pocketed bets. The firm doesn't define its investment focus by fixed industry sectors, instead tracking underlying drivers of structural change. Its portfolio already spans healthcare, renewable energy, supply chain infrastructure, alternative credit, space transportation, and advanced materials.
Notable portfolio companies include Timee, which IPO'd on the Tokyo Stock Exchange in July 2024, and HRBrain, which exited via secondary sale to European fund EQT in 2023. In Southeast Asia, the firm has backed regional platforms like Docquity and Qoala in Indonesia, along with Vietnamese startups Buymed, KAMEREO, and Fundiin.
Founder and general partner Soichi Tajima said the firm will keep backing founders "operating at the intersection of transformational changes and pursuing opportunities with the potential to create significant societal impact."
